Fund shareholders of Ocugen Inc
ISIN US67577C1053 · United States · LEI 549300JVNUI9CXWJLR09
- Fund shareholders
- 28
- Of which ETFs
- 4 24 other funds
- Value held
- 50.1M $
- Share of capital
- 8.2 % of 339.1M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 9,801,994 | 17.7M $ | 0.00 % | 2.89 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 5,222,819 | 9.5M $ | 0.13 % | 1.54 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,665,453 | 6.6M $ | 0.01 % | 1.08 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 2,554,326 | 4.6M $ | 0.20 % | 0.75 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 1,639,988 | 3M $ | 0.01 % | 0.48 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 939,571 | 1.7M $ | 0.01 % | 0.28 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 645,821 | 1.2M $ | 0.00 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 582,856 | 1.1M $ | 0.00 % | 0.17 % | as of Feb 28, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 548,690 | 949.2K $ | 0.59 % | 0.16 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 449,915 | 818.8K $ | 0.00 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 304,496 | 526.8K $ | 0.10 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 210,254 | 363.7K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 187,541 | 339.4K $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 183,068 | 333.2K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 175,442 | 303.5K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 146,991 | 266.1K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 114,536 | 198.1K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 94,238 | 163K $ | 0.09 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 78,538 | 142.2K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 49,386 | 85.4K $ | 0.02 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 36,556 | 63.2K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 29,074 | 52.6K $ | 0.13 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 22,064 | 39.9K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 7,448 | 13.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 5,289 | 9.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 4,900 | 8.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 3,448 | 6.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Small Cap Index V.I. Fund BlackRock Variable Series Funds, Inc. | 1,394 | 2.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 0.59 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 0.20 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.13 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.13 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.10 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 0.09 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 0.02 % | as of Apr 30, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 0.01 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 0.01 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 28 | +4 | 27,706,096 | +32.2 % |
| 2026Q1 | 24 | +3 | 20,952,841 | +25.8 % |
| 2025Q4 | 21 | -26 | 16,657,846 | -21.8 % |
| 2025Q3 | 47 | -37 | 21,312,487 | -43.8 % |
| 2025Q2 | 84 | 0 | 37,930,693 | -0.9 % |
| 2025Q1 | 84 | -4 | 38,291,276 | -19.8 % |
| 2024Q4 | 88 | +43 | 47,745,104 | +49.9 % |
| 2024Q3 | 45 | +28 | 31,850,609 | +112.4 % |
| 2024Q2 | 17 | -1 | 14,994,909 | +1.0 % |
| 2024Q1 | 18 | -4 | 14,843,779 | -6.5 % |
| 2023Q4 | 22 | 15,882,341 |
Institutional managers
132 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 13,727,192 | 24.8M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 9,670,191 | 17.5M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 8,052,350 | 14.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 7,304,979 | 13.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 7,280,320 | 13.2M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 6,666,666 | 12.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,227,104 | 7.7M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 3,962,972 | 7.2M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 3,773,066 | 6.8M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 3,678,655 | 6.7M $ | as of Mar 31, 2026 |
| GMT Capital Corp | 3,505,398 | 6.3M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,809,157 | 5.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 2,251,282 | 4.1M $ | as of Mar 31, 2026 |
| Hennion & Walsh Asset Management, Inc. | 1,276,725 | 2.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,174,180 | 2.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,127,406 | 2M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,097,742 | 2M $ | as of Mar 31, 2026 |
| Rinkey Investments | 1,032,989 | 1.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 834,490 | 1.5M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 769,549 | 1.4M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 713,736 | 1.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 677,906 | 1.2M $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 582,052 | 1.1K $ | as of Mar 31, 2026 |
| Voleon Capital Management LP | 485,247 | 878.3K $ | as of Mar 31, 2026 |
| Brevan Howard Capital Management LP | 448,162 | 811.2K $ | as of Mar 31, 2026 |
Declared shareholders of Ocugen Inc
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Millennium Management LLC and 2 others | 5.20 % | 17,074,584 | as of Apr 9, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Ocugen Inc". https://titelia.com/en/stocks/ocugen-inc-US67577C1053